Showing results (61-70 of 93) with videos related to

Sort By:
Pageof 10
Leukemia & Lymphoma|January 20, 2021
A phase I trial evaluating the effects of plerixafor, G-CSF, and azacitidine for the treatment of myelodysplastic syndromesEric Huselton, Michael P Rettig, Theresa Fletcher, et al.
Blood|March 16, 2017
Mobilization of allogeneic peripheral blood stem cell donors with intravenous plerixafor mobilizes a unique graftMark A Schroeder, Michael P Rettig, Sandra Lopez, et al.
Cancer Genetics|March 6, 2026
Exome sequencing of Hodgkin and non-Hodgkin composite lymphomas identifies shared somatic mutations indicative of common founding precursorsFelicia Gomez, Lauren Shea, Sivasankar Annamalai Sharavanan, et al.
Cancer Medicine|October 24, 2017
Patterns of infectious complications in acute myeloid leukemia and myelodysplastic syndromes patients treated with 10-day decitabine regimenAlaa M Ali, Daniel Weisel, Feng Gao, et al.
Blood|November 15, 2021
Phase 1/dose expansion trial of brentuximab vedotin and lenalidomide in relapsed or refractory diffuse large B-cell lymphomaJeffrey P Ward, Melissa M Berrien-Elliott, Felicia Gomez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 2, 2015
The IL-15-Based ALT-803 Complex Enhances FcγRIIIa-Triggered NK Cell Responses and In Vivo Clearance of B Cell LymphomasMaximillian Rosario, Bai Liu, Lin Kong, et al.
Blood|July 3, 2020
CAR-modified memory-like NK cells exhibit potent responses to NK-resistant lymphomasMargery Gang, Nancy D Marin, Pamela Wong, et al.
The New England Journal of Medicine|August 1, 2019
Ibrutinib-Rituximab or Chemoimmunotherapy for Chronic Lymphocytic LeukemiaTait D Shanafelt, Xin V Wang, Neil E Kay, et al.
Blood Advances|December 3, 2021
Outcome of allogeneic transplantation for mature T-cell lymphomas: impact of donor source and disease characteristicsMehdi Hamadani, Maud Ngoya, Anna Sureda, et al.
Blood|October 6, 2018
The phase 3 DUO trial: duvelisib vs ofatumumab in relapsed and refractory CLL/SLLIan W Flinn, Peter Hillmen, Marco Montillo, et al.
Pageof 10